UAB Pharma Nord Lithuania Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
431,209 |
51,031 |
21,406 |
6,208 |
735 |
5.42 |
1.44 |
15,393 |
102,257 |
0 |
117,650 |
2022 |
---|
266,104 |
45,488 |
13,305 |
13,109 |
2,241 |
5.89 |
4.93 |
17,502 |
73,022 |
0 |
90,524 |
2023 |
---|
352,698 |
80,341 |
28,184 |
22,308 |
5,082 |
9.02 |
6.32 |
39,810 |
91,754 |
8,081 |
122,858 |
Register and
explore Okredo data2023 |
---|
352,698 |
80,341 |
28,184 |
22,308 |
5,082 |
9.02 |
6.32 |
39,810 |
91,754 |
8,081 |
122,858 |
Register and
explore Okredo data2023
Turnover (€)
352,698 €33 % *
Sales per employee (€)
80,341 €77 % *
Profit before tax (€)
28,184 €112 % *
Net Profit (€)
22,308 €70 % *
Profit per employee (€)
5,082 €127 % *
Total profitability (%)
9.02 %53.14 % *
Net profitability (%)
6.32 %28.19 % *
Equity (€)
39,810 €127 % *
Amounts Payable And Liabilities (€)
91,754 €26 % *
Non-current Assets (€)
8,081 €- *
CurrentAssets (€)
122,858 €36 % *